Bioneer Corporation (KOSDAQ:064550)
12,930
+300 (2.38%)
At close: Feb 9, 2026
Bioneer Revenue
Bioneer had revenue of 88.07B KRW in the quarter ending September 30, 2025, with 33.67% growth. This brings the company's revenue in the last twelve months to 320.69B, up 11.48% year-over-year. In the year 2024, Bioneer had annual revenue of 293.98B with 11.68% growth.
Revenue (ttm)
320.69B
Revenue Growth
+11.48%
P/S Ratio
1.04
Revenue / Employee
873.82M
Employees
367
Market Cap
333.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 293.98B | 30.74B | 11.68% |
| Dec 31, 2023 | 263.24B | 44.84B | 20.53% |
| Dec 31, 2022 | 218.39B | -5.35B | -2.39% |
| Dec 31, 2021 | 223.74B | 16.76B | 8.10% |
| Dec 31, 2020 | 206.99B | 170.70B | 470.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EASY BIO,Inc. | 465.24B |
| Macrogen | 179.98B |
| BINEX | 165.64B |
| JETEMA, | 75.55B |
| HLB Therapeutics | 63.25B |
| SillaJen | 7.84B |
| Anterogen.Co.,Ltd. | 7.32B |
| Genexine | 5.81B |